The battle against the stem cell hype: Are we doing enough? Can the medical and scientific community do more to support regulatory boards in advocating ethical evidence-based medicine?

Abstract

This article highlights the current controversies around stem cell research and its application in clinical medicine. It aims to discuss the ethical concerns around how corporate involvement is corrupting the ethical progression in this field of research. The author appeals to medical and scientific communities to take cognisance of current practices and to facilitate the regulation of new stem cell therapies being advertised to the public.